×
About 44,112 results

ALLMedicine™ Ulcerative Colitis Center

Research & Reviews  20,717 results

Not all nodules with PET hypermetabolic activity are malignant: a case of lung granulom...
https://doi.org/10.1136/bcr-2021-242154
BMJ Case Reports; Chong WH, Ibrahim A et. al.

Apr 13th, 2021 - Not all nodules with PET hypermetabolic activity are malignant: a case of lung granuloma in ulcerative colitis.|2021|Chong WH,Ibrahim A,Saha BK,|

Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in ...
https://doi.org/10.1093/ibd/izab063
Inflammatory Bowel Diseases; Manzini R, Schwarzfischer M et. al.

Apr 13th, 2021 - Vedolizumab is a widely used and safe therapy in inflammatory bowel disease, particularly in ulcerative colitis (UC), making it a promising candidate for enhanced efficacy by combining it with additional immunomodulatory medications. In this study...

Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relap...
https://doi.org/10.1093/ibd/izab062
Inflammatory Bowel Diseases; Asonuma K, Kobayashi T et. al.

Apr 13th, 2021 - Mucosal healing is a treatment target for patients with ulcerative colitis. However, the relevance of proactive treatment for residual inflammation limited to the distal colon is unclear. Patients with ulcerative colitis who had extensive colitis ...

Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mous...
https://doi.org/10.1080/01635581.2021.1909737
Nutrition and Cancer; Mashtoub S, Chartier LC et. al.

Apr 12th, 2021 - Ulcerative colitis patients have an increased risk of developing colorectal cancer (CRC). The aim of the current study was to determine whether Emu Oil (EO) could reduce the severity of colitis, thereby inhibiting colitis-associated CRC (CA-CRC) d...

see more →

Guidelines  87 results

Spatialization in working memory: can individuals reverse the cultural direction of the...
https://doi.org/10.1016/j.gastrohep.2020.05.009
Annals of the New York Academy of Sciences References; Muñoz F, Ripollés T et. al.

Sep 26th, 2020 - Ultrasound has an excellent diagnostic performance when Crohn's disease is suspected, when performing an activity assessment, or determining the extension and location of Crohn's disease, very similar to other examinations such as MRI or CT. It ha...

Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcera...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology

Mar 28th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|

Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Mar 14th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Col...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175923
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Jan 16th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|therapeutic use,standards,diagnosis,immunology,therapy,diagnostic imaging,immunology,p...

Management of ulcerative colitis: summary of updated NICE guidance.
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.

Oct 29th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,

see more →

Drugs  289 results see all →

Clinicaltrials.gov  21,799 results

Not all nodules with PET hypermetabolic activity are malignant: a case of lung granulom...
https://doi.org/10.1136/bcr-2021-242154
BMJ Case Reports; Chong WH, Ibrahim A et. al.

Apr 13th, 2021 - Not all nodules with PET hypermetabolic activity are malignant: a case of lung granuloma in ulcerative colitis.|2021|Chong WH,Ibrahim A,Saha BK,|

Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in ...
https://doi.org/10.1093/ibd/izab063
Inflammatory Bowel Diseases; Manzini R, Schwarzfischer M et. al.

Apr 13th, 2021 - Vedolizumab is a widely used and safe therapy in inflammatory bowel disease, particularly in ulcerative colitis (UC), making it a promising candidate for enhanced efficacy by combining it with additional immunomodulatory medications. In this study...

Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relap...
https://doi.org/10.1093/ibd/izab062
Inflammatory Bowel Diseases; Asonuma K, Kobayashi T et. al.

Apr 13th, 2021 - Mucosal healing is a treatment target for patients with ulcerative colitis. However, the relevance of proactive treatment for residual inflammation limited to the distal colon is unclear. Patients with ulcerative colitis who had extensive colitis ...

Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mous...
https://doi.org/10.1080/01635581.2021.1909737
Nutrition and Cancer; Mashtoub S, Chartier LC et. al.

Apr 12th, 2021 - Ulcerative colitis patients have an increased risk of developing colorectal cancer (CRC). The aim of the current study was to determine whether Emu Oil (EO) could reduce the severity of colitis, thereby inhibiting colitis-associated CRC (CA-CRC) d...

see more →

News  1,165 results

Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
https://www.medscape.com/viewarticle/946797

Mar 2nd, 2021 - Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis (UC), according to a press release from manufacturer AbbVie. Approval...

PICaSSO Tool Promising for Predicting Histologic Remission in Ulcerative Colitis
https://www.medscape.com/viewarticle/946588

Feb 28th, 2021 - NEW YORK (Reuters Health) - The recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) accurately identified both endoscopic and histologic remission in ulcerative colitis (UC) and predicted specified clinical outcomes...

Ustekinumab Works Well in Ulcerative Colitis in the General Population
https://www.medscape.com/viewarticle/946043

Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...

Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Me...
https://www.fda.gov/safety/medical-product-safety-information/xeljanz-xeljanz-xr-tofacitinib-drug-safety-communication-initial-safety-trial-results-find-increased

[Posted 02/04/2021] AUDIENCE: Patient, Health Professional, Pharmacy, Rheumatology, Gastroenterology, Cardiology, Oncology  ISSUE: The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serio...

IV Ferric Carboxymaltose Tops IV Iron Sucrose for Iron-deficiency Anemia in IBD
https://www.medscape.com/viewarticle/945009

Feb 1st, 2021 - NEW YORK (Reuters Health) - For iron-deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD), intravenous ferric carboxymaltose is probably a better bet than IV iron sucrose, according to a Cochrane review of therapies to treat I...

see more →

Patient Education  55 results see all →